RNeasy Mini Kit

High-quality total RNA in minutes.

Investigator 24plex QS Kit

Multiplex amplification for human ID, with CODIS and European standard markers.

QIAsphere

Monitor and manage your QIAsphere-ready instruments from anywhere, using any mobile device.

Smart ideas, deep insights

Get inspiring content today – with a free face mask.

QIAGEN Clinical Insight (QCI) Interpret

Transparent, evidence-based NGS interpretation and reporting.

Find out more

QIAGENbioinformatics.com

COVID-19 testing and research

Up to date protocols and list of COVID-19 testing and research solutions.

RNeasy Mini Kit

High-quality total RNA in minutes.

Smart ideas, deep insights

Get inspiring content today – with a free face mask.

QuantiFERON-TB Gold Plus

Detect TB infection with confidence.

QIAGEN Clinical Insight (QCI) Interpret

Transparent, evidence-based NGS interpretation and reporting.

QIAGEN Deep Dive – QIAcuity digital PCR

Home  >  Investor Relations  >  Events & Presentations  >  QIAGEN Deep Dive – QIAcuity digital PCR

QIAGEN Deep Dive – QIAcuity digital PCR

This session in our QIAGEN Deep Dives series focused on QIAcuity, QIAGEN’s digital PCR solution.

The session offered insights into how QIAGEN is driving adoption of QIAcuity digital PCR, expanding into new application areas and building its position. The program featured customer voices and perspectives from QIAGEN experts.

Downloads

Watch the QIAcuity digital PCR Deep Dive on-demand

Full event replay
Detection. Quantification. Confidence.
Digital PCR differentiation and applications
Business perspectives
Companion diagnostics interview
Concluding remarks
Q&A

Speaker bios

Download all

See how QIAcuity digital PCR is used to address complex scientific challenges

Delivering faster quantified answers for sepsis care

Sepsis demands fast diagnostic answers. At Brown University Health, QIAcuityDx digital PCR enables highly sensitive detection and quantification of pathogen RNA, delivering results in approximately five hours. QIAcuityDx supports clinical decision-making and more targeted treatment for sepsis patients.

Streamlining scalable MRD testing

Detecting MRD requires exceptional sensitivity to identify low levels of tumor DNA in blood samples. At Tracer Bio, QIAcuity supports cancer monitoring. Combined with an automation-friendly workflow, QIAcuity has transformed assay development, reducing manual effort.

Strengthening food safety through digital PCR

At Florida State University, QIAcuity digital PCR enables researchers to quantify Salmonella and E. coli in poultry and beef samples. By delivering absolute quantification, accurate results in complex food matrices and supporting multiplex detection, FSU is protecting consumers from foodborne illness.

Driving precision in translational medicine

Novel therapies require highly sensitive analytical methods to detect subtle biological changes with confidence. At Novartis, QIAcuity digital PCR enables precise quantification in AAV shedding studies, supporting regulatory requirements, reducing hands-on time and helping advance the development of precision medicines.

Enabling scalable cell therapy manufacturing

At Cellares, QIAcuity digital PCR supports vector copy number analysis and safety assays with precise, absolute quantification, helping detect low-level contamination. By enabling high-throughput workflows it strengthens quality control for scalable cell therapy manufacturing.

Unlocking public health insights from wastewater

Wastewater monitoring requires reliable methods to detect public health threats in complex environmental samples. Berliner Wasserbetriebe leverages QIAcuity digital PCR to enable accurate wastewater surveillance. Its sensitivity and robustness supports monitoring of water quality and public health.

Identifying the genetics behind obesity using dPCR

Obesity is one of the world’s most complex chronic diseases, with genetics playing a critical role in determining individual risk. Dr. Johanna Andersson-Assarsson’s research highlights how QIAcuity digital PCR enables precise copy number analysis, helping uncover genetic factors that could advance future obesity therapies and research.

  Learn More  

A new climate for vector-borne diseases

As climate change reshapes the spread of vector-borne diseases, researchers are turning to digital PCR to better understand emerging health risks. Dr. Melissa Nolan’s work highlights how QIAcuity digital PCR supports sensitive detection and helps advance public health research in a changing world.

  Learn More  

A life after the first successful pediatric CAR T-cell Therapy

After becoming the first child successfully treated with CAR-T cell therapy, Emily Whitehead’s journey became a milestone in cancer research. Her story showcases how advances in cell and gene therapy are helping transform scientific discovery into real-world patient benefit.

  Learn More